Schalon Newton, D.M.
Chair, ANRF Board of Directors
Trefoil Therapeutics
Chief Business Officer
Why Schalon Newton is involved in ANRF:
“With family members who have arthritis I am acutely aware of the challenges of this category of diseases and the limitations that exist with currently available therapies. The early research support that ANRF provides for innovative new approaches to the diagnosis and treatment of these autoimmune conditions is a critical need as government funding is under increasing pressure and corporations increasingly prioritize spending on development projects rather than pure research. ANRF is a uniquely focused organization with the single goal of advancing early stage research.”